Post-pandemic Era Global Insulin Syringes Market Segment Research Report 2024
Summary
The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Insulin Syringes market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Insulin Syringes market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Insulin Syringes production is XX (K Units). US market value in 2021 is about USD XX billion, and US Insulin Syringes production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Insulin Syringes production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Insulin Syringes Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Insulin Syringes Market?
BD
Smiths Medical
Terumo Medical Corporation
Montmed Inc
CHINA VIOMED
Ambisea Technology
Henke-Sass
Jiangsu Kangjin Medical Instruments
Jiangsu Kangyou Medical Instrument
Millpledge
Nipro
Rays
Romed Holland
Trividia Health
Troge Medical
UltiMed Inc
Vogt Medical
Major Type of Insulin Syringes Covered in MR Accuracy Reports report
U-100 Type
U-40 Type
Others
Application Segments Covered in MR Accuracy Reports Market
Hospitals
Clinics
Home Care
Others
For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content
Table of Contents
Global Insulin Syringes Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Insulin Syringes Market by Value
2.2.1 Global Insulin Syringes Revenue by Type
2.2.2 Global Insulin Syringes Market by Value (%)
2.3 Global Insulin Syringes Market by Production
2.3.1 Global Insulin Syringes Production by Type
2.3.2 Global Insulin Syringes Market by Production (%)
3. The Major Driver of Insulin Syringes Industry
3.1 Historical & Forecast Global Insulin Syringes Demand
3.2 Largest Application for Insulin Syringes (2017-2027)
3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Insulin Syringes Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Insulin Syringes Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Insulin Syringes Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Insulin Syringes Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Insulin Syringes Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Insulin Syringes Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Insulin Syringes Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Insulin Syringes Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Insulin Syringes Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Insulin Syringes Average Price Trend
12.1 Market Price for Each Type of Insulin Syringes in US (2017-2021)
12.2 Market Price for Each Type of Insulin Syringes in Europe (2017-2021)
12.3 Market Price for Each Type of Insulin Syringes in China (2017-2021)
12.4 Market Price for Each Type of Insulin Syringes in Japan (2017-2021)
12.5 Market Price for Each Type of Insulin Syringes in India (2017-2021)
12.6 Market Price for Each Type of Insulin Syringes in Korea (2017-2021)
12.7 Market Price for Each Type of Insulin Syringes in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
13.1 Insulin Syringes Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Insulin Syringes
14. Insulin Syringes Competitive Landscape
14.1 BD
14.1.1 BD Company Profiles
14.1.2 BD Product Introduction
14.1.3 BD Insulin Syringes Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Smiths Medical
14.2.1 Smiths Medical Company Profiles
14.2.2 Smiths Medical Product Introduction
14.2.3 Smiths Medical Insulin Syringes Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Terumo Medical Corporation
14.3.1 Terumo Medical Corporation Company Profiles
14.3.2 Terumo Medical Corporation Product Introduction
14.3.3 Terumo Medical Corporation Insulin Syringes Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Montmed Inc
14.4.1 Montmed Inc Company Profiles
14.4.2 Montmed Inc Product Introduction
14.4.3 Montmed Inc Insulin Syringes Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 CHINA VIOMED
14.5.1 CHINA VIOMED Company Profiles
14.5.2 CHINA VIOMED Product Introduction
14.5.3 CHINA VIOMED Insulin Syringes Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Ambisea Technology
14.6.1 Ambisea Technology Company Profiles
14.6.2 Ambisea Technology Product Introduction
14.6.3 Ambisea Technology Insulin Syringes Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Henke-Sass
14.7.1 Henke-Sass Company Profiles
14.7.2 Henke-Sass Product Introduction
14.7.3 Henke-Sass Insulin Syringes Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Jiangsu Kangjin Medical Instruments
14.8.1 Jiangsu Kangjin Medical Instruments Company Profiles
14.8.2 Jiangsu Kangjin Medical Instruments Product Introduction
14.8.3 Jiangsu Kangjin Medical Instruments Insulin Syringes Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Jiangsu Kangyou Medical Instrument
14.9.1 Jiangsu Kangyou Medical Instrument Company Profiles
14.9.2 Jiangsu Kangyou Medical Instrument Product Introduction
14.9.3 Jiangsu Kangyou Medical Instrument Insulin Syringes Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 Millpledge
14.10.1 Millpledge Company Profiles
14.10.2 Millpledge Product Introduction
14.10.3 Millpledge Insulin Syringes Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 Nipro
14.12 Rays
14.13 Romed Holland
14.14 Trividia Health
14.15 Troge Medical
14.16 UltiMed Inc
14.17 Vogt Medical
15. Conclusion
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Insulin Syringes Industry (Volume)
Figure 2. Insulin Syringes Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Insulin Syringes Revenue in 2021
Figure 5. US Insulin Syringes Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Insulin Syringes Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Insulin Syringes Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Insulin Syringes Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Insulin Syringes Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Insulin Syringes Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Insulin Syringes Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Insulin Syringes Revenue, by Type (Million USD) (2017-2027)
Table 4. Insulin Syringes Production, by Type (K Unit) (2017-2027)
Table 5. Insulin Syringes Demand (K Unit) by Application (2017-2027)
Table 6. Insulin Syringes Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Insulin Syringes Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Insulin Syringes Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Insulin Syringes in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Insulin Syringes in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Insulin Syringes in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Insulin Syringes in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Insulin Syringes in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Insulin Syringes in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Insulin Syringes in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. BD Profiles
Table 61. BD Insulin Syringes Product Introduction
Table 62. BD Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. BD Strategic initiatives
Table 64. Smiths Medical Profiles
Table 65. Smiths Medical Insulin Syringes Product Introduction
Table 66. Smiths Medical Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Smiths Medical Strategic initiatives
Table 68. Terumo Medical Corporation Profiles
Table 69. Terumo Medical Corporation Insulin Syringes Product Introduction
Table 70. Terumo Medical Corporation Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Terumo Medical Corporation Strategic initiatives
Table 72. Montmed Inc Profiles
Table 73. Montmed Inc Insulin Syringes Product Introduction
Table 74. Montmed Inc Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Montmed Inc Strategic initiatives
Table 76. CHINA VIOMED Profiles
Table 77. CHINA VIOMED Insulin Syringes Product Introduction
Table 78. CHINA VIOMED Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. CHINA VIOMED Strategic initiatives
Table 80. Ambisea Technology Profiles
Table 81. Ambisea Technology Insulin Syringes Product Introduction
Table 82. Ambisea Technology Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Ambisea Technology Strategic initiatives
Table 84. Henke-Sass Profiles
Table 85. Henke-Sass Insulin Syringes Product Introduction
Table 86. Henke-Sass Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Henke-Sass Strategic initiatives
Table 88. Jiangsu Kangjin Medical Instruments Profiles
Table 89. Jiangsu Kangjin Medical Instruments Insulin Syringes Product Introduction
Table 90. Jiangsu Kangjin Medical Instruments Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Jiangsu Kangjin Medical Instruments Strategic initiatives
Table 92. Jiangsu Kangyou Medical Instrument Profiles
Table 93. Jiangsu Kangyou Medical Instrument Insulin Syringes Product Introduction
Table 94. Jiangsu Kangyou Medical Instrument Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. Jiangsu Kangyou Medical Instrument Strategic initiatives
Table 97. Millpledge Profiles
Table 98. Millpledge Insulin Syringes Product Introduction
Table 99. Millpledge Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. Millpledge Strategic initiatives
Table 101. Nipro Profiles
Table 102. Nipro Insulin Syringes Product Introduction
Table 103. Nipro Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 104. Nipro Strategic initiatives
Table 105. Rays Profiles
Table 106. Rays Insulin Syringes Product Introduction
Table 107. Rays Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 108. Rays Strategic initiatives
Table 109. Romed Holland Profiles
Table 110. Romed Holland Insulin Syringes Product Introduction
Table 111. Romed Holland Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 112. Romed Holland Strategic initiatives
Table 113. Trividia Health Profiles
Table 114. Trividia Health Insulin Syringes Product Introduction
Table 115. Trividia Health Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 116. Trividia Health Strategic initiatives
Table 117. Troge Medical Profiles
Table 118. Troge Medical Insulin Syringes Product Introduction
Table 119. Troge Medical Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 120. Troge Medical Strategic initiatives
Table 121. UltiMed Inc Profiles
Table 122. UltiMed Inc Insulin Syringes Product Introduction
Table 123. UltiMed Inc Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)
Table 124. UltiMed Inc Strategic initiatives
Table 125. Vogt Medical Profiles
Table 126. Vogt Medical Insulin Syringes Product Introduction
Table 127. Vogt Medical Insulin Syringes Sales (Unit), Revenue (Million USD) (2017-2021)